Miltenyi Biotec Presentation: Automated & Closed Manufacturing of Engineered NK Cell Therapies
Thursday, May 30, 2024 10:30 AM - 10:45 AM
Exhibit Hall - Theatre B
Global Showcase Presentation
Presenter
Engineered NK cell therapies represent a promising next horizon for CGT. However, there are still many hurdles to overcome to advance this modality, including difficulties in transgene expression, challenges in allogeneic manufacturing, and the development of a scalable GMP-ready process.
At Miltenyi Bioindustry, we’ve integrated our product, reagent, and process expertise to create comprehensive CDMO services specifically geared to the needs of NK cell therapy developers.
Come learn about Miltenyi Bioindustry’s CDMO services can support you at every step of your NK cell therapy workflow:
• Real world clinical experience with NK cell therapy process development and manufacturing
• Lentiviral vector capabilities for NKs with our BaEV LVV platform
• Closed manufacturing platform and process development experts capable of supporting autologous and allogeneic processes
• Standardized packages for NK cell transduction and IPC/QC
• Comprehensive global support for regulatory filings
- Ian Gaudet, PhD, Chief Scientific Director, Miltenyi Bioindustry, United States
Engineered NK cell therapies represent a promising next horizon for CGT. However, there are still many hurdles to overcome to advance this modality, including difficulties in transgene expression, challenges in allogeneic manufacturing, and the development of a scalable GMP-ready process.
At Miltenyi Bioindustry, we’ve integrated our product, reagent, and process expertise to create comprehensive CDMO services specifically geared to the needs of NK cell therapy developers.
Come learn about Miltenyi Bioindustry’s CDMO services can support you at every step of your NK cell therapy workflow:
• Real world clinical experience with NK cell therapy process development and manufacturing
• Lentiviral vector capabilities for NKs with our BaEV LVV platform
• Closed manufacturing platform and process development experts capable of supporting autologous and allogeneic processes
• Standardized packages for NK cell transduction and IPC/QC
• Comprehensive global support for regulatory filings
SPONSORED BY:
